Advent Life Sciences is a transatlantic venture capital firm focused on building and investing in innovative life sciences businesses across the UK, Europe and the United States. The firm specialises in early and mid-stage companies developing new medicines, medical technologies and enabling platforms.
Advent focuses primarily on novel drug discovery programmes across a range of modalities, as well as medtech, vaccines and other healthcare technologies. The firm works closely with founders and management teams to support the development and commercialisation of breakthrough scientific innovations.
With an experienced investment team and a long-standing presence in the life sciences sector, Advent aims to translate cutting-edge research into successful healthcare companies capable of delivering new treatments and improving patient outcomes.
Reason for commitment from British Business Bank
The British Business Bank has been an investor in Advent Life Sciences funds through commitments to the current Growth Fund I and the 2019 vintage Advent Life Sciences III venture fund supporting their venture and growth strategies. Advent Life Sciences aligns with the Bank’s objective to support UK’s most promising companies developing novel therapeutics across the full breadth of the life sciences sector.
Previous investments by the manager
- KaNDy Therapeutics
- Nalu Medical
- Miro Therapeutics
- Levicept
- Orphalan
- Axonics
- Amphista
- Cyted
Advent Life Sciences Growth Fund has completed full British Business Bank due diligence, and received Investment Committee approval.
-
Fund Manager
Advent Life Sciences
-
Based in
London, UK
-
Stage
Growth stage
-
Industrial Strategy Sectors
Life Sciences (BioPharma and MedTech)
-
Structure
On-shore English Limited Partnership
-
Fundraising target
£200 million - £300 million
-
British Business Bank Commitment
£75 million
Disclaimer
This website includes information about UK investment funds in which one or more entities within the British Business Bank group (“BBB Group”) may be investors. This information is provided for information purposes only – it has no regard to the specific investment objectives or particular needs of any person and does not constitute an offer, recommendation, or financial promotion under applicable legislation. The BBB Group does not market or make investment opportunities available to the public. Fund details are provided by external sources and the BBB Group does not verify their accuracy. Fund investments involve significant risk, including the risk of losing capital.
Access to this website is intended for authorised persons only. Users are responsible for complying with local laws and regulations regarding access. Any investment enquiries must be directed to the relevant fund manager and any investment decisions must be based solely on information provided by the relevant fund or fund manager.